Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
about
Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cellsGsdma3 gene is needed for the induction of apoptosis-driven catagen during mouse hair follicle cycleAlteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancerDifferential response to zinc-induced apoptosis in benign prostate hyperplasia and prostate cancer cells.Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cellsFunctional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control studySAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protectionThe enigmatic roles of caspases in tumor developmentSeoritae extract reduces prostate weight and suppresses prostate cell proliferation in a rat model of benign prostate hyperplasia.Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases.Immunohistochemical expression of caspase-1 and -9, uncleaved caspase-3 and -6, cleaved caspase-3 and -6 as well as Bcl-2 in benign epithelium and cancer of the prostate.Terazosin treatment induces caspase-3 expression in the rat ventral prostate.Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.Inhibitors of apoptosis proteins in prostate cancer cell lines.
P2860
Q24801685-EB719734-3E33-4FB6-A1B5-26331B2A37AEQ28512579-6D2D987D-D454-4B9C-BA64-B2A5E918667EQ33236893-69F1D307-3C13-4867-BB51-18F894ED4B9FQ34015344-328E60AB-8FD8-458E-B59C-472FC782A060Q34015365-F63CEAE4-7F13-43A0-A841-2839E944AA4FQ34863364-34CC3574-3275-49FD-A702-E8AF9B871747Q35613215-C643D29E-AEE9-4F8A-9BA1-66A21E9395C2Q37342739-3CF6546B-CA0A-49A8-88DA-FB5443181A78Q37631419-CBFFF139-4613-4BF2-94FB-3DD86F68AEF3Q40763240-DF60541F-450E-482F-9111-D29FED650FACQ41459871-77586739-71D2-472F-8D3C-0116BE633B4CQ42573911-1C90EAAD-CBBA-4564-A2B9-101C7EBC9BC0Q43114709-AD37CD5B-F43E-4220-BE28-81398C2AD153Q43956511-B1435955-3AD4-44E0-9F29-FE863F3B2BA2
P2860
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@en
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@nl
type
label
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@en
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@nl
prefLabel
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@en
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
@en
P2093
Fitzpatrick JM
Gaffney EF
Hegarty NJ
O'Neill AJ
P2860
P304
P356
10.1002/PROS.1061
P577
2001-05-01T00:00:00Z